AAAAAA

   
Results: 1-20 |
Results: 20
PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT
Authors: CHEN Y LELEU G RIBAUD P AZOULAY E SOCIE G GLUCKMAN E SCHLEMMER B
Citation: Y. Chen et al., PREDICTIVE FACTORS OF DEATH IN BMT PATIENTS ADMITTED TO INTENSIVE-CARE UNIT, Bone marrow transplantation, 21, 1998, pp. 306-306
OROPHARYNGEAL OR GASTRIC COLONIZATION AND NOSOCOMIAL PNEUMONIA IN ADULT INTENSIVE-CARE UNIT PATIENTS - A PROSPECTIVE-STUDY BASED ON GENOMICDNA ANALYSIS
Authors: GARROUSTEORGEAS M CHEVRET S ARLET G MARIE O ROUVEAU M POPOFF N SCHLEMMER B
Citation: M. Garrousteorgeas et al., OROPHARYNGEAL OR GASTRIC COLONIZATION AND NOSOCOMIAL PNEUMONIA IN ADULT INTENSIVE-CARE UNIT PATIENTS - A PROSPECTIVE-STUDY BASED ON GENOMICDNA ANALYSIS, American journal of respiratory and critical care medicine, 156(5), 1997, pp. 1647-1655
FALCIPARUM-MALARIA - AN INFECTIOUS CAUSE OF RHABDOMYOLYSIS AND ACUTE-RENAL-FAILURE
Authors: ALLO JC VINCENT F BARBOTEU M SCHLEMMER B
Citation: Jc. Allo et al., FALCIPARUM-MALARIA - AN INFECTIOUS CAUSE OF RHABDOMYOLYSIS AND ACUTE-RENAL-FAILURE, Nephrology, dialysis, transplantation, 12(9), 1997, pp. 2033-2034
SHORT AND LONG-TERM OUTCOMES FOR PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES ADMITTED TO INTENSIVE-CARE UNITS - A PROGNOSTIC STUDY OF 181 PATIENTS
Authors: GODEAU B MORTIER E ROY PM CHEVRET S BOUACHOUR G SCHLEMMER B CARLET J DHAINAUT JF CHASTANG C
Citation: B. Godeau et al., SHORT AND LONG-TERM OUTCOMES FOR PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES ADMITTED TO INTENSIVE-CARE UNITS - A PROGNOSTIC STUDY OF 181 PATIENTS, Journal of rheumatology, 24(7), 1997, pp. 1317-1323
OPTIMAL USE OF ANTIMICROBIALS IN HOSPITAL IZED-PATIENTS - RECOMMENDATIONS FOR LIMITING THE EMERGENCE OF BACTERIAL-RESISTANCE
Authors: CARLET J CORDONNIER C DECAZES JM KORINEK AM PETITPRETZ P ROTMAN N ACAR J BENHAMOU D BEYTOUT J BUISSON Y CHOUTET P DUROCHER A JARLIER V MLIKACABANNE N MONNET D REGNIER B RICHET H SCHLEMMER B SINEGRE M SOUSSY CJ TREMOLIERES F VERNETGARNIER V WOLFF M ABADIE E ARDUIN M BECKGIRAUDON B BEDOCK B BERARDI L BERNARD C BLECH MF BORNET JL BOULARD G BRUNBUISSON C CARBON C CHAPERON J CHARBONNEAU P COURVALIN P DAVID P DEMICCO P DESBONNETS GP DELCOURT S DEROUBAIX P DESFARGES R DHAVELOOZE A DIEN G DRUCKER J DUBERNET J DUBOIS D DUCREUX AM DUROUX P DUTILLEUL P FABRE X FABRY J FAGNIEZ PL FLANDROIS JP FRANCIOLI P GACHIE JP GALLIACI JL GOTTOT S GOUET D GOUIN F HOUSSIN D JONQUET O JOURDAN J LABADIE JC LACORE V LAGEL R LAXENAIRE MC LEJEUNE B LEMAIRE C LEROY J MAZEMAN P MECHALY P MERY D MICOUD M MOULRONT S NORDIN JY NOUVEAU J PENALBA C PORTIER H POUPENEY M RAZES C RIGNIER P ROUBERTIE E THABAUT A VEYSSIER P VIBET MN WEBER M WELCKER Y WITVOET J
Citation: J. Carlet et al., OPTIMAL USE OF ANTIMICROBIALS IN HOSPITAL IZED-PATIENTS - RECOMMENDATIONS FOR LIMITING THE EMERGENCE OF BACTERIAL-RESISTANCE, La Semaine des hopitaux de Paris, 73(5-6), 1997, pp. 153-158
FULMINANT PNEUMOCYSTIS-CARINII PNEUMONIA IN 4 PATIENTS WITH DERMATOMYOSITIS
Authors: BACHELEZ H SCHREMMER B CADRANEL J MOULY F SARFATI C AGBALIKA F SCHLEMMER B MAYAUD CM DUBERTRET L
Citation: H. Bachelez et al., FULMINANT PNEUMOCYSTIS-CARINII PNEUMONIA IN 4 PATIENTS WITH DERMATOMYOSITIS, Archives of internal medicine, 157(13), 1997, pp. 1501-1503
HOW TO DIAGNOSE STREPTOCOCCAL PHARYNGITIS
Authors: GHANASSIA JP REINERT P BERCHE P BIANCHI M BINGEN E COHEN R GEHANNO P GARNIER JM MARTIN P OLIVIER C PESSEY JJ PORTIER H SCHLEMMER B SCHLEMMER C STEHLE B
Citation: Jp. Ghanassia et al., HOW TO DIAGNOSE STREPTOCOCCAL PHARYNGITIS, Archives de pediatrie, 3(8), 1996, pp. 749-751
SECONDARY CARRIAGE WITH MULTIRESISTANT ACINETOBACTER-BAUMANNII AND KLEBSIELLA-PNEUMONIAE IN AN ADULT ICU POPULATION - RELATIONSHIP WITH NOSOCOMIAL INFECTIONS AND MORTALITY
Authors: GARROUSTEORGEAS M MARIE O ROUVEAU M VILLIERS S ARLET G SCHLEMMER B
Citation: M. Garrousteorgeas et al., SECONDARY CARRIAGE WITH MULTIRESISTANT ACINETOBACTER-BAUMANNII AND KLEBSIELLA-PNEUMONIAE IN AN ADULT ICU POPULATION - RELATIONSHIP WITH NOSOCOMIAL INFECTIONS AND MORTALITY, The Journal of hospital infection, 34(4), 1996, pp. 279-289
THE IMPACT OF EUROPEAN FUNDS IN SUPPORT O F SCIENTIFIC COOPERATION FOR DEVELOPING-COUNTRIES
Authors: ARVANITIS R GAILLARD J CHATELIN Y MEYER JB SCHLEMMER B WAAST R
Citation: R. Arvanitis et al., THE IMPACT OF EUROPEAN FUNDS IN SUPPORT O F SCIENTIFIC COOPERATION FOR DEVELOPING-COUNTRIES, Interciencia, 20(2), 1995, pp. 76-82
CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK
Authors: DHAINAUT JFA VINCENT JL RICHARD C LEJEUNE P MARTIN C FIEROBE L STEPHENS S NEY UM SOPWITH M MERCAT A EDOUARD A FRIEDMAN G MARIN N SCHLEMMER B LEPAPE A NOVAK C
Citation: Jfa. Dhainaut et al., CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK, Critical care medicine, 23(9), 1995, pp. 1461-1469
SEVERE COMMUNITY-ACQUIRED PNEUMOCOCCAL PNEUMONIA
Authors: MOINE P VERCKEN JB CHEVRET S GAJDOS P SCHLEMMER B GARROUSTE MT MUIR JF DEFOUILLOY C THALER F TENAILLON A CARLET J TIMSIT JF VERCKEN JB GAJDOS P DEROHANCHABOT P BOLES JM OUTIN H TEMPE JD SCHNEIDER F HOLZAPFEL L SOLLET JP PETITPRETZ P FRAISSE F GBIKPIBENISSIAN G CARDINAUD JP BRUNBUISSON C
Citation: P. Moine et al., SEVERE COMMUNITY-ACQUIRED PNEUMOCOCCAL PNEUMONIA, Scandinavian journal of infectious diseases, 27(3), 1995, pp. 201-206
REAL PART DETERMINATION OFDR WITH DIGITAL SPATIAL-FILTERING
Authors: SCHLEMMER B WINTER A
Citation: B. Schlemmer et A. Winter, REAL PART DETERMINATION OFDR WITH DIGITAL SPATIAL-FILTERING, IEEE photonics technology letters, 6(8), 1994, pp. 1011-1013
CEFPIROME MULTICENTER STUDY IN INTENSIVE- CARE UNIT
Authors: LEGALL JR BRUNBUISSON C CARLET J LECLERCQ B SCHLEMMER B SOLLET JP WOLFF M
Citation: Jr. Legall et al., CEFPIROME MULTICENTER STUDY IN INTENSIVE- CARE UNIT, Medecine et maladies infectieuses, 24(11), 1994, pp. 1184-1189
PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL
Authors: DHAINAUT JFA TENAILLON A LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP DEVATHAIRE F GUINOT P
Citation: Jfa. Dhainaut et al., PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL, Critical care medicine, 22(11), 1994, pp. 1720-1728
METHODOLOGY IN EVALUATION OF DRUG IN CHRONIC-BRONCHITIS
Authors: AUBIER M CANET E ARNAUD F",BERDAH,"DUCHIER J DUROUX P FOURNIER M JIROUNAJOU JL LEPECQ JB MARTHAN R PAPO M RENAUD S SCHLEMMER B
Citation: M. Aubier et al., METHODOLOGY IN EVALUATION OF DRUG IN CHRONIC-BRONCHITIS, Therapie, 49(3), 1994, pp. 245-249
ANTIBIOTIC STRATEGY IN FEBRILE EPISODES D URING SEVERE LONG-TERM NEUTROPENIA (BELOW 500-PNN FOR 7 OR MORE DAYS) - RECOMMENDATIONS OF THE COMMISSION-DEVALUATION OF THE COLLEGE-FRANCAISE-DES-HEMATOLOGISTES
Authors: CORDONNIER C LEVERGER G SCHLEMMER B ANDREMONT A BOASSON M HERBRECHT R KAZMIERCZAK A MARIE JP MARIT G MICLEA JM MONCONDUIT M RAIN JD RICHET H VARET B WATTEL E
Citation: C. Cordonnier et al., ANTIBIOTIC STRATEGY IN FEBRILE EPISODES D URING SEVERE LONG-TERM NEUTROPENIA (BELOW 500-PNN FOR 7 OR MORE DAYS) - RECOMMENDATIONS OF THE COMMISSION-DEVALUATION OF THE COLLEGE-FRANCAISE-DES-HEMATOLOGISTES, Nouvelle revue francaise d'hematologie, 36(4), 1994, pp. 289-291
SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, EPIDEMIOLOGY, AND PROGNOSIS FACTORS
Authors: MOINE P VERCKEN JB CHEVRET S CHASTANG C GAJDOS P SCHLEMMER B GARROUSTE MT MUIR JF DEFOUILLOY C THALER F TENAILLON A CARLET J TIMSIT JF DEROHANCHABOT P BOLES JM OUTIN H TEMPE JD SCHNEIDER F HOLZAPFEL L SOLLET JP PETITPRETZ P FRAISSE F GBIKPIBENISSIAN G CARDINAUD JP BRUNBUISSON C
Citation: P. Moine et al., SEVERE COMMUNITY-ACQUIRED PNEUMONIA - ETIOLOGY, EPIDEMIOLOGY, AND PROGNOSIS FACTORS, Chest, 105(5), 1994, pp. 1487-1495
FOLLOW-UP OF 161 PATIENTS WITH SYSTEMIC-D ISEASES AFTER ADMISSION FORINTENSIVE-CARE
Authors: MORTIER E GODEAU B ROY PM DHAINAUT JF SCHLEMMER B CARLET J ALQUIER P SCHAEFFER A CHASTANG C
Citation: E. Mortier et al., FOLLOW-UP OF 161 PATIENTS WITH SYSTEMIC-D ISEASES AFTER ADMISSION FORINTENSIVE-CARE, La Revue de medecine interne, 14(10), 1993, pp. 973-973
EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS
Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97
EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS
Authors: TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P
Citation: A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 196-196
Risultati: 1-20 |